Загрузка...
One year survivor of metastatic renal cell carcinoma treated with pazopanib
Tyrosine kinase inhibitor (TKI) and its side effects are well known. However, these are mainly descriptive, with pictorial data lacking. Here, in we report a case of metastatic renal cell carcinoma, treated with TKI, with classic side effects; supplemented with images that demonstrate the adverse ef...
Сохранить в:
| Опубликовано в: : | Urol Ann |
|---|---|
| Главные авторы: | , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Medknow Publications & Media Pvt Ltd
2017
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5405669/ https://ncbi.nlm.nih.gov/pubmed/28479777 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/0974-7796.204178 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|